Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Viscosupplementation is the process by which the synovial fluid at the joints is replaced by a hyaluronate preparation which has viscous properties similar to the natural synovial fluid. GlobalData uses proprietary data and analytics to provide a comprehensive report on the viscosupplementation market in Israel. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the viscosupplementation market in Israel was Sanofi followed by Ferring Pharmaceuticals, Fidia farmaceutici, Zimmer Biomet and Anika Therapeutics.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints. Other joints include hip, shoulder, ankle, elbow, wrist, hand and foot. Viscosupplementation consists of a treatment cycle of hyaluronic acid injections which come in variable volumes. One cycle is comprised of 1-injection or 3-injection or 5-injection course. Hyaluronic acid is given as a one-dose injection. Hyaluronic acid is given as a three-dose injection over three weeks. Hyaluronic acid is given as a five-dose injection over five weeks.
The viscosupplementation market in Israel can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size viscosupplementation in Israel, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
